During the past decade, Hosp de Olhos de Sorocaba conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hosp de Olhos de Sorocaba" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hosp de Olhos de Sorocaba" are "Diabetic Macular Edema" (2 trials), "Macular Edema" (2 trials), "Branch Retinal Vein Occlusion" (1 trials), "Central Retinal Vein Occlusion" (1 trials) and "Hemiretinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Hosp de Olhos de Sorocaba" in a lesser frequency.

Most popular intervention types in "Hosp de Olhos de Sorocaba" are "Drug" (5 trials), "Procedure" (3 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (4 trials), "Sham Procedure" (4 trials), "Aflibercept" (3 trials), "Port Delivery System with Ranibizumab" (1 trials) and "Ranibizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hosp de Olhos de Sorocaba" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Hosp de Olhos de Sorocaba". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hosp de Olhos de Sorocaba, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hosp de Olhos de Sorocaba, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".